Augurex Life Sciences, Quest Diagnostics collaborate to improve rheumatoid arthritis diagnosis and management: Vancouver, Canada Monday, November 18, 2024, 16:00 Hrs [IST] Augurex ...
Quest to introduce lab-developed test based on Augurex 14-3-3η (eta) biomarker to U.S. physicians later this month Augurex Life Sciences Corp., a leader in autoimmune biomarker-based diagnostics ...
Quest to introduce lab-developed test based on Augurex 14-3-3η (eta) biomarker to U.S. physicians later this month VANCOUVER, British Columbia, November 15, 2024--(BUSINESS WIRE)--Augurex Life ...
VANCOUVER, British Columbia--(BUSINESS WIRE)--Augurex Life Sciences Corp., a leader in autoimmune biomarker-based diagnostics, today announced that it has formed a nonexclusive agreement with ...
VANCOUVER, British Columbia & KNOXVILLE, Tenn.--(BUSINESS WIRE)--Augurex Life Sciences Corp. (“Augurex”) today announced the launch of Anti-14-3-3eta Multiplex Analyte Specific Reagents (ASRs ...
Quest to introduce lab-developed test based on Augurex 14-3-3η (eta) biomarker to U.S. physicians later this month VANCOUVER, British Columbia, November 15, 2024--(BUSINESS WIRE)--Augurex Life ...
The test will measure levels of the 14-3-3eta protein, which is used in the diagnosis and management of inflammatory diseases including rheumatoid arthritis.
VANCOUVER, British Columbia — Augurex Life Sciences Corp., a leader in autoimmune biomarker-based diagnostics, today announced that it has formed a nonexclusive agreement with Quest Diagnostics, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback